HCPCS code J9357: Valrubicin, per 200 mg2026 Medicare rate & RVUs

J9357 reports valrubicin placed directly into the bladder, generally for persistent bladder carcinoma in situ after intravesical BCG treatment.

CMS RVU26DEffective Oct 1, 2026109 payment localities

Medicare rate · J9357

Valrubicin, per 200 mg

Office or facility?

Work RVUs
0
Total RVUs
0.00
Global days
XXX

National rate · 2026

—

Not priced in the facility setting.

See every locality for J9357 →Billed by an NP, PA or therapist? →

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

Your location

Medicare pays by the payment locality where the service is performed.

On this page 10 sections
  1. Medicare rate
  2. What J9357 covers
  3. By payment locality
  4. Rate map
  5. How it’s calculated
  6. Payment rules
  7. Similar codes
  8. Related codes
  9. Billing questions
  10. Sources

What J9357 covers

Valrubicin is an antineoplastic drug delivered directly into the bladder through a urinary catheter, not by intravenous infusion. Urologists use it for adults with bladder carcinoma in situ that persists or returns after intravesical BCG, particularly when cystectomy is not an appropriate option. The drug code represents the medication; CPT 51720 represents the bladder instillation service.

Each J9357 unit represents 200 mg of valrubicin, so an 800-mg administration is four units. CMS assigns physician fee schedule status E, excluding the drug from that schedule. When Medicare covers it, payment is made through another method. HCPCS classifies it as a Part B drug generally paid using CMS quarterly ASP drug pricing files when covered. Its CMS coverage code indicates that special Medicare coverage instructions apply.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J9357 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

J9357 office and facility rates by payment locality
Payment localityOfficeFacility
AlabamaUnavailableUnavailable
AlaskaUnavailableUnavailable
ArizonaUnavailableUnavailable
ArkansasUnavailableUnavailable
Atlanta, GAUnavailableUnavailable
Austin, TXUnavailableUnavailable
Bakersfield, CAUnavailableUnavailable
Baltimore area, MDUnavailableUnavailable
Beaumont, TXUnavailableUnavailable
Brazoria, TXUnavailableUnavailable

J9357 rates by state

Office rate range in each state. Select a state to see its payment localities.

Explore a state

Local rates. Clear comparisons.

Hover or focus a tile to see its rate range. Select it to open the state’s fee schedule.

View every state and territory as a table
J9357 office rate range by state
State / territoryOffice rate rangeLocalities
AKNo published base rate1
ALNo published base rate1
ARNo published base rate1
AZNo published base rate1
CANo published base rate29
CONo published base rate1
CTNo published base rate1
DCNo published base rate1
DENo published base rate1
FLNo published base rate3
GANo published base rate2
GUNo published base rate1
HINo published base rate1
IANo published base rate1
IDNo published base rate1
ILNo published base rate4
INNo published base rate1
KSNo published base rate1
KYNo published base rate1
LANo published base rate2
MANo published base rate2
MDNo published base rate3
MENo published base rate2
MINo published base rate2
MNNo published base rate1
MONo published base rate3
MSNo published base rate1
MTNo published base rate1
NCNo published base rate1
NDNo published base rate1
NENo published base rate1
NHNo published base rate1
NJNo published base rate2
NMNo published base rate1
NVNo published base rate1
NYNo published base rate5
OHNo published base rate1
OKNo published base rate1
ORNo published base rate2
PANo published base rate2
PRNo published base rate1
RINo published base rate1
SCNo published base rate1
SDNo published base rate1
TNNo published base rate1
TXNo published base rate8
UTNo published base rate1
VANo published base rate2
VINo published base rate1
VTNo published base rate1
WANo published base rate2
WINo published base rate1
WVNo published base rate1
WYNo published base rate1

How the J9357 rate is calculated

Each of J9357’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

How the rate is built · J9357

RVUs × geographic indexes × conversion factor

Office or facility?

Work0.00

0.00 RVUs× 1.000 GPCI

Practice expense0.00

0.00 RVUs× 1.000 GPCI

Malpractice0.00

0.00 RVUs× 1.000 GPCI

Adjusted RVUs

0.0000

Conversion factor

$33.4009

Medicare rate

$0.00

Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.

Payment rules and modifiers for J9357

J9357 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

Place of service · J9357

Which rate does Medicare pay?

The POS code on the claim line (CMS-1500 box 24B).

POS 11 · non-facility rate · national

—

J9357 isn’t priced in this setting.

J9357 compared with similar codes

Compare codes · National

4 codes, side by side

Office or facility?

  • J9357

    Valrubicin, per 200 mg0 wRVU

    Not priced

  • 51720

    Bladder instillation, antineoplastic agent0.85 wRVU

    $91.85

  • J9030

    Intravesical BCG, per 1 mg0 wRVU

    Not priced

  • J9201

    Gemcitabine injection, per 200 mg0 wRVU

    Not priced

How to choose

51720Bladder instillationAntineoplastic agent
51720 represents the bladder instillation service; J9357 represents the valrubicin drug and its administered amount.
J9030Intravesical BCGPer 1 mg
J9030 identifies intravesical BCG, not valrubicin. The drugs have different roles in bladder cancer treatment.
J9201Gemcitabine injectionPer 200 mg
J9201 identifies gemcitabine, not valrubicin. Select the drug code that matches the medication administered.

J9357 billing questions

How many J9357 units represent an 800-mg dose?

Each unit represents 200 mg, so 800 mg is four units. Base the reported units on the amount administered.

Does J9357 represent the bladder instillation procedure?

No. J9357 represents the valrubicin drug. CPT 51720 represents bladder instillation of an anticarcinogenic agent.

How does Medicare classify payment for J9357?

CMS assigns status E, excluding J9357 from the physician fee schedule. When covered, Medicare pays through another method; HCPCS classifies it as a Part B drug generally paid using quarterly ASP drug pricing files.

What documentation supports the J9357 units?

Record the valrubicin amount administered and its intravesical route so the reported units reflect the administered dose.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates

Did this answer your question about what J9357 pays?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put J9357 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist